» Articles » PMID: 35746025

In Vitro Biocompatibility of a Novel Semi-Rigid Shell Barrier System: As a New Application for Guided Bone Regeneration

Overview
Publisher MDPI
Date 2022 Jun 24
PMID 35746025
Authors
Affiliations
Soon will be listed here.
Abstract

This study evaluated the in vitro biocompatibility of a novel, semi-rigid shell barrier system for guided bone regeneration (GBR) based on polycaprolactone and biphasic calcium phosphate membranes and consisting of a semi-rigid shell (SR) and two semi-resorbable barrier membranes, i.e., a buffered (BF) and an airdried (AD) membrane. In vitro biocompatibility, cell cytotoxicity, cell proliferation and differentiation were evaluated with osteoblast (MC3T3-E1) and fibroblast (L929) cells compared to the d-PTFE membrane (Cytoplast, CP). The osteoblasts and fibroblasts were well attached and proliferated on all materials from days 1, 3, and 7 without cell cytotoxicity. All groups showed that osteoblast and fibroblast cell proliferation increased from day 1 to day 14-17 and decreased on day 21. On day 21, the CP membrane presented significantly higher osteoblast cell numbers than the BF membrane and the SR shell ( = 0.000). The CP membrane presented a significantly higher amount of fibroblast cells than the other groups ( = 0.000). The SR shell and the BF membrane demonstrated higher osteoblast cell differentiation markers including ALP activity, osteocalcin, and mineral secretion than the CP and the AD membrane. The semi-rigid shell barrier system demonstrated good in vitro biocompatibility and supported osteogenic cell proliferation and differentiation better than the d-PTFE membrane.

Citing Articles

LINC00941 affects the proliferation, apoptosis and differentiation of osteoblasts by regulating the miR-335-5p/KAT7 axis.

Liu L, Yang Y, Sun P J Orthop Surg Res. 2025; 20(1):75.

PMID: 39838460 PMC: 11749574. DOI: 10.1186/s13018-025-05469-w.


LncRNA MAGI2-AS3 promotes fracture healing through downregulation of miR-223-3p.

Dong Z, Hu B, Wang S, Wang M, Sun S, Liu X J Orthop Surg Res. 2024; 19(1):370.

PMID: 38907263 PMC: 11193218. DOI: 10.1186/s13018-024-04850-5.

References
1.
Ebrahimi M, Pripatnanont P, Monmaturapoj N, Suttapreyasri S . Fabrication and characterization of novel nano hydroxyapatite/β-tricalcium phosphate scaffolds in three different composition ratios. J Biomed Mater Res A. 2012; 100(9):2260-8. DOI: 10.1002/jbm.a.34160. View

2.
Jung R, Kokovic V, Jurisic M, Yaman D, Subramani K, Weber F . Guided bone regeneration with a synthetic biodegradable membrane: a comparative study in dogs. Clin Oral Implants Res. 2011; 22(8):802-7. DOI: 10.1111/j.1600-0501.2010.02068.x. View

3.
Yang F, Both S, Yang X, Walboomers X, Jansen J . Development of an electrospun nano-apatite/PCL composite membrane for GTR/GBR application. Acta Biomater. 2009; 5(9):3295-304. DOI: 10.1016/j.actbio.2009.05.023. View

4.
Bingham P, Raisz L . Bone growth in organ culture: effects of phosphate and other nutrients on bone and cartilage. Calcif Tissue Res. 1974; 14(1):31-48. DOI: 10.1007/BF02060281. View

5.
Engelberg I, Kohn J . Physico-mechanical properties of degradable polymers used in medical applications: a comparative study. Biomaterials. 1991; 12(3):292-304. DOI: 10.1016/0142-9612(91)90037-b. View